|
WO2020230792A1
|
|
Method for determining eligibility of cancer patients for peptide vaccine therapy
|
|
JP2005099001A
|
|
Method of measuring anti-peptide antibody, and method of selecting vaccine candidate of peptide vaccine
|
|
JP2005162679A
|
|
Peptide recognized by cd4-positive t-cell
|
|
JP2004141154A
|
|
Tumor antigen
|
|
JP2004000216A
|
|
Tumor antigen
|
|
JP2004150997A
|
|
Method of measureing cytokine
|
|
JP2003111595A
|
|
Tumor antigen
|
|
JP2003000270A
|
|
Tumor antigen
|
|
JP2002365286A
|
|
Cellular immunity detecting method and its application to physic
|
|
JP2001245675A
|
|
Tumor antigen
|
|
JP2000247994A
|
|
Peptide originating from yeast and having tumor antigenic peptide activity
|
|
JP2000116383A
|
|
Human cancer regression antigen protein
|
|
JPH11318455A
|
|
Human cancer regression antigenic protein
|
|
JPH0650975A
|
|
Judging method for existence of oncocyte
|
